Document ID: chunk:federal_register_of_legislation:C2020A00075:clause:8_4
Version: federal_register_of_legislation:C2020A00075
Segment Type: clause
Provision Reference: sch 8 cl 4
Character Range: 27945–29401

4  Subsection 29(3)
Repeal the subsection, substitute:
 (3) Subject to this section, the provisional registration period, for a medicine that is provisionally registered because of an application that, under subsection 23AA(1), is taken to be an application for provisional registration of the medicine, is the period of 2 years starting on the day the registration commences.
Note: Subsection 25AB(6) provides that registration commences on the day specified in the certificate of registration.
 (3A) Subject to this section, the provisional registration period, for a medicine (the new medicine) that is provisionally registered because of an application that, under subsection 23AA(2), is taken to be an application for provisional registration of the new medicine, is as follows:
 (a) if, in relation to the new medicine, the day (the start day) referred to in subsection 25AB(6) occurs in the period (the original period) referred to in subsection (3) of this section in relation to the original medicine concerned—the period starting on the start day and ending at the end of the original period;
 (b) if, in relation to the new medicine, the start day occurs in a period of extension of the original period that is granted under subsection (6)—the period starting on the start day and ending at the end of that extension period.
Note: Subsection 25AB(6) provides that registration commences on the day specified in the certificate of registration.